Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids - PubMed

Review

Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids

Alexandre Umpierrez Amaral et al. Neurochem Int. 2022 Jul.

Abstract

Maple syrup urine disease (MSUD) is an autosomal recessive neurometabolic disorder caused by severe deficiency of branched-chain α-keto acid dehydrogenase complex activity, which catalyzes the oxidative decarboxylation of the branched-chain α-keto acids (BCKA). The metabolic blockage results in tissue accumulation and high urinary excretion of the branched-chain amino acids (BCAA) leucine, isoleucine and valine, as well as alloisoleucine, and their respective BCKA α-ketoisocaproic (α-KIC), α-ketoisovaleric and α-keto-β-methylvaleric acids. Affected patients usually manifest acute episodes of encephalopathy associated with seizures, coma and life-threatening cerebral edema in the first weeks of life, which is followed by progressive neurological deterioration with motor delay, ataxia, intellectual disability and psychiatric symptoms. The pathophysiology of the brain damage in MSUD has been mainly focused on brain amino acid imbalance leading to deficient cerebral protein and neurotransmitter synthesis. However, the acute episodes of severe neurological symptoms accompanied by large increases of BCKA/BCAA levels suggest neurotoxic actions of these compounds. In this particular, mounting evidence from humans and animal models support an important role of particularly leucine and α-KIC on the pathogenesis of the brain injury in MSUD. In this review we will present the current knowledge of the major mechanisms presumably involved in MSUD neuropathology and highlight the neurotoxic properties of the BCAA and BCKA, disturbing brain bioenergetics and redox homeostasis, besides inducing neuroinflammation. We suggest that these pathomechanisms may contribute to the neurological sequelae of MSUD patients and hopefully allow the design of novel therapeutic strategies, including antioxidant and bioenergetics stimulating drugs targeting the mitochondria.

Keywords: Bioenergetics; Branched-chain amino acids; Branched-chain α-keto acids; Maple syrup urine disease; Neuroinflammation; Redox homeostasis.

Similar articles

• Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.

  Mescka CP, Wayhs CA, Guerreiro G, Manfredini V, Dutra-Filho CS, Vargas CR. Mescka CP, et al. Gene. 2014 Sep 15;548(2):294-8. doi: 10.1016/j.gene.2014.07.051. Epub 2014 Jul 18. Gene. 2014. PMID: 25046137

• Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.

  Funchal C, Latini A, Jacques-Silva MC, Dos Santos AQ, Buzin L, Gottfried C, Wajner M, Pessoa-Pureur R. Funchal C, et al. Neurochem Int. 2006 Dec;49(7):640-50. doi: 10.1016/j.neuint.2006.05.007. Epub 2006 Jul 5. Neurochem Int. 2006. PMID: 16822590

• Acute effects of intracerebroventricular administration of α-ketoisocaproic acid in young rats on inflammatory parameters.

  Rabelo F, Lemos IDS, Dal Toé CP, Casagrande DD, Freitas MLS, Quadra MR, Lima IR, Generoso JS, Michels M, Silveira PCL, Pizzol FD, Streck EL. Rabelo F, et al. Metab Brain Dis. 2023 Jun;38(5):1573-1579. doi: 10.1007/s11011-023-01193-8. Epub 2023 Mar 10. Metab Brain Dis. 2023. PMID: 36897514

• Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.

  Deon M, Guerreiro G, Girardi J, Ribas G, Vargas CR. Deon M, et al. Int J Dev Neurosci. 2023 Oct;83(6):489-504. doi: 10.1002/jdn.10283. Epub 2023 Jun 20. Int J Dev Neurosci. 2023. PMID: 37340513 Review.

• Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.

  Xu J, Jakher Y, Ahrens-Nicklas RC. Xu J, et al. Int J Mol Sci. 2020 Oct 11;21(20):7490. doi: 10.3390/ijms21207490. Int J Mol Sci. 2020. PMID: 33050626 Free PMC article. Review.

Cited by

• Branched-chain amino acids: physico-chemical properties, industrial synthesis and role in signaling, metabolism and energy production.

  Reifenberg P, Zimmer A. Reifenberg P, et al. Amino Acids. 2024 Aug 28;56(1):51. doi: 10.1007/s00726-024-03417-2. Amino Acids. 2024. PMID: 39198298 Free PMC article. Review.

• Exposure to leucine alters glutamate levels and leads to memory and social impairment in zebrafish.

  da Silva Lemos I, Wessler LB, Duarte MB, da Silva GL, Bernardo HT, Candiotto G, Torres CA, Petronilho F, Rico EP, Streck EL. da Silva Lemos I, et al. Metab Brain Dis. 2022 Dec;37(8):2925-2935. doi: 10.1007/s11011-022-01070-w. Epub 2022 Aug 30. Metab Brain Dis. 2022. PMID: 36040712

• Intravenous branched-chain amino-acid-free solution for the treatment of metabolic decompensation episodes in Spanish pediatric patients with maple syrup urine disease.

  Sánchez-Pintos P, Meavilla S, López-Ramos MG, García-Cazorla Á, Couce ML. Sánchez-Pintos P, et al. Front Pediatr. 2022 Aug 15;10:969741. doi: 10.3389/fped.2022.969741. eCollection 2022. Front Pediatr. 2022. PMID: 36046474 Free PMC article.

• In Vivo Intracerebral Administration of α-Ketoisocaproic Acid to Neonate Rats Disrupts Brain Redox Homeostasis and Promotes Neuronal Death, Glial Reactivity, and Myelination Injury.

  Zemniaçak ÂB, Ribeiro RT, Pinheiro CV, de Azevedo Cunha S, Tavares TQ, Castro ET, Leipnitz G, Wajner M, Amaral AU. Zemniaçak ÂB, et al. Mol Neurobiol. 2024 May;61(5):2496-2513. doi: 10.1007/s12035-023-03718-9. Epub 2023 Nov 1. Mol Neurobiol. 2024. PMID: 37910283

• Exploratory Untargeted Metabolomics of Dried Blood Spot Samples from Newborns with Maple Syrup Urine Disease.

  Alotaibi AZ, AlMalki RH, Al Mogren M, Sebaa R, Alanazi M, Jacob M, Alodaib A, Alfares A, Abdel Rahman AM. Alotaibi AZ, et al. Int J Mol Sci. 2024 May 24;25(11):5720. doi: 10.3390/ijms25115720. Int J Mol Sci. 2024. PMID: 38891907 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Medical

  • Genetic Alliance